{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:18:15Z","timestamp":1769105895200,"version":"3.49.0"},"publisher-location":"Cham","reference-count":72,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319596587","type":"print"},{"value":"9783319596594","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/164_2017_25","type":"book-chapter","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T16:49:18Z","timestamp":1491410958000},"page":"537-560","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Role of Hyperkalemia in Heart Failure and the Therapeutic Use of Potassium Binders"],"prefix":"10.1007","author":[{"given":"Chaudhry M. S.","family":"Sarwar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditi A.","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,6]]},"reference":[{"issue":"9","key":"25_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.mayocp.2013.06.005","volume":"88","author":"KJ Aaron","year":"2013","unstructured":"Aaron KJ, Sanders PW (2013) Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence. Mayo Clin Proc 88(9):987\u2013995","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"25_CR2","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1001\/archinte.158.8.917","volume":"158","author":"CG Acker","year":"1998","unstructured":"Acker CG et al (1998) Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 158(8):917\u2013924","journal-title":"Arch Intern Med"},{"issue":"2","key":"25_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","volume":"149","author":"KF Adams Jr","year":"2005","unstructured":"Adams KF Jr et al (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149(2):209\u2013216","journal-title":"Am Heart J"},{"issue":"4","key":"25_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000013599","volume":"20","author":"TS Ahuja","year":"2000","unstructured":"Ahuja TS et al (2000) Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors. Am J Nephrol 20(4):268\u2013272","journal-title":"Am J Nephrol"},{"issue":"4","key":"25_CR5","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S0272-6386(96)90460-6","volume":"28","author":"M Allon","year":"1996","unstructured":"Allon M, Shanklin N (1996) Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol. Am J Kidney Dis 28(4):508\u2013514","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"25_CR6","doi-asserted-by":"publisher","first-page":"R225","DOI":"10.1186\/cc11872","volume":"16","author":"JN An","year":"2012","unstructured":"An JN et al (2012) Severe hyperkalemia requiring hospitalization: predictors of mortality. Crit Care 16(6):R225","journal-title":"Crit Care"},{"issue":"10","key":"25_CR7","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/ejhf.300","volume":"17","author":"SD Anker","year":"2015","unstructured":"Anker SD et al (2015) Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial. Eur J Heart Fail 17(10):1050\u20131056","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"25_CR8","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ki.2014.382","volume":"88","author":"SR Ash","year":"2015","unstructured":"Ash SR et al (2015) A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient. Kidney Int 88(2):404\u2013411","journal-title":"Kidney Int"},{"issue":"2","key":"25_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/jama.2015.7446","volume":"314","author":"GL Bakris","year":"2015","unstructured":"Bakris GL et al (2015) Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: the AMETHYST-DN randomized clinical trial. JAMA 314(2):151\u2013161","journal-title":"JAMA"},{"issue":"2","key":"25_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0022-0736(75)80028-8","volume":"8","author":"TT Bashour","year":"1975","unstructured":"Bashour TT et al (1975) Complete heart block with normal QRS duration occurring distal to the his bundle in acute inferior myocardial infarction. J Electrocardiol 8(2):185\u2013190","journal-title":"J Electrocardiol"},{"issue":"1","key":"25_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ejhf.444","volume":"18","author":"P Bramlage","year":"2016","unstructured":"Bramlage P et al (2016) Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease. Eur J Heart Fail 18(1):28\u201337","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"25_CR13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1161\/CIRCHEARTFAILURE.113.000981","volume":"7","author":"J Butler","year":"2014","unstructured":"Butler J, Givertz MM (2014) Response to sexton: inhibiting the renin-angiotensin-aldosterone system in patients with heart failure and renal dysfunction: common sense or nonsense? Circ Heart Fail 7(3):537\u2013540","journal-title":"Circ Heart Fail"},{"issue":"10","key":"25_CR14","doi-asserted-by":"publisher","first-page":"28E","DOI":"10.1016\/0002-9149(90)90249-Z","volume":"65","author":"HJ Dargie","year":"1990","unstructured":"Dargie HJ (1990) Interrelation of electrolytes and renin-angiotensin system in congestive heart failure. Am J Cardiol 65(10):28E\u201332E. Discussion 52E","journal-title":"Am J Cardiol"},{"key":"25_CR15","unstructured":"Department of Health and Human Services, P. H. S., Food and Drug Administration (2015) Risk assessment and risk mitigation review. Center for Drug Evaluation and Research"},{"issue":"3","key":"25_CR77","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S0002-8703(96)90253-7","volume":"132","author":"S Douban","year":"1996","unstructured":"Douban S, Brodsky MA, Whang DD, Whang R (1996) Significance of magnesium in congestive heart failure. Am Heart J 132(3):664\u2013671","journal-title":"Am Heart J"},{"issue":"1","key":"25_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5414\/CN108334","volume":"83","author":"Y Einbinder","year":"2015","unstructured":"Einbinder Y et al (2015) Sodium polystyrene sulfonate \u2013 is it truly effective treatment for hyperkalemia? Clin Nephrol 83(1):71\u201372","journal-title":"Clin Nephrol"},{"key":"25_CR17","unstructured":"Epstein M, Mayo M, Garza D, Zawadzki R, Berman L, Wilson DJ, Bakris G (2016) Strategy for improved blood pressure (BP) control in resistant hypertension (RH) with diabetic kidney disease (DKD). Poster number 313. Presented at the National Kidney Foundation Meeting, May 2016. http:\/\/ww3.aievolution.com\/nkf1601\/index.cfm?do=abs.viewAbs&src=ext&abs=1101"},{"key":"25_CR18","unstructured":"FDA (2014) Open-label safety & efficacy of ZS (sodium zirconium cyclosilicate)10g qd to extend study ZS-004 in hyperkalemia. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02107092?term=sodium+zirconium&rank=2 . Accessed 17 Dec 2015"},{"issue":"7","key":"25_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/BF02233563","volume":"11","author":"JS Fordtran","year":"1966","unstructured":"Fordtran JS, Locklear TW (1966) Ionic constituents and osmolality of gastric and small-intestinal fluids after eating. Am J Dig Dis 11(7):503\u2013521","journal-title":"Am J Dig Dis"},{"key":"25_CR20","unstructured":"Fulton T (n.d.) Lecture on \u201cDiffusion and transport across cell membranes\u201d. http:\/\/biochemistry.ucsf.edu\/programs\/ptf\/prologue"},{"issue":"13","key":"25_CR21","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296\u20131305","journal-title":"N Engl J Med"},{"issue":"18","key":"25_CR22","first-page":"1787","volume":"373","author":"ML Gumz","year":"2015","unstructured":"Gumz ML et al (2015) An integrated view of potassium homeostasis. N Engl J Med 373(18):1787\u20131788","journal-title":"N Engl J Med"},{"issue":"3","key":"25_CR23","doi-asserted-by":"publisher","first-page":"264.e269\u2013224","DOI":"10.1016\/j.amjmed.2012.08.016","volume":"126","author":"Z Harel","year":"2013","unstructured":"Harel Z et al (2013) Gastrointestinal adverse events with sodium polystyrene sulfonate (kayexalate) use: a systematic review. Am J Med 126(3):264.e269\u2013224","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"25_CR25","first-page":"183","volume":"88","author":"J Holtz","year":"1993","unstructured":"Holtz J (1993) Pathophysiology of heart failure and the renin-angiotensin-system. Basic Res Cardiol 88(Suppl 1):183\u2013201","journal-title":"Basic Res Cardiol"},{"issue":"10","key":"25_CR26","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.amjcard.2012.01.367","volume":"109","author":"N Jain","year":"2012","unstructured":"Jain N et al (2012) Predictors of hyperkalemia and death in patients with cardiac and renal disease. Am J Cardiol 109(10):1510\u20131513","journal-title":"Am J Cardiol"},{"issue":"6","key":"25_CR27","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1056\/NEJMoa040135","volume":"351","author":"DN Juurlink","year":"2004","unstructured":"Juurlink DN et al (2004) Rates of hyperkalemia after publication of the randomized Aldactone evaluation study. N Engl J Med 351(6):543\u2013551","journal-title":"N Engl J Med"},{"issue":"3","key":"25_CR28","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/jhm.834","volume":"6","author":"C Kessler","year":"2011","unstructured":"Kessler C et al (2011) The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia. J Hosp Med 6(3):136\u2013140","journal-title":"J Hosp Med"},{"issue":"2","key":"25_CR29","doi-asserted-by":"publisher","first-page":"251","DOI":"10.5114\/aoms.2014.42577","volume":"10","author":"J Khanagavi","year":"2014","unstructured":"Khanagavi J et al (2014) Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes. Arch Med Sci 10(2):251\u2013257","journal-title":"Arch Med Sci"},{"issue":"9704","key":"25_CR30","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/S0140-6736(09)61913-9","volume":"374","author":"MA Konstam","year":"2009","unstructured":"Konstam MA et al (2009) Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial. Lancet 374(9704):1840\u20131848","journal-title":"Lancet"},{"issue":"21","key":"25_CR31","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1001\/jama.2014.15688","volume":"312","author":"M Kosiborod","year":"2014","unstructured":"Kosiborod M et al (2014) Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial. JAMA 312(21):2223\u20132233","journal-title":"JAMA"},{"issue":"12","key":"25_CR32","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.2215\/CJN.03640415","volume":"10","author":"L Lepage","year":"2015","unstructured":"Lepage L et al (2015) Randomized clinical trial of sodium polystyrene sulfonate for the treatment of mild hyperkalemia in CKD. Clin J Am Soc Nephrol 10(12):2136\u20132142","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"25_CR33","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1177\/1074248416629549","volume":"21","author":"L Li","year":"2016","unstructured":"Li L et al (2016) Mechanism of action and pharmacology of patiromer, a Nonabsorbed cross-linked polymer that lowers serum potassium concentration in patients with hyperkalemia. J Cardiovasc Pharmacol Ther 21(5):456\u2013465","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"1","key":"25_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2215\/CJN.01730215","volume":"11","author":"J Luo","year":"2016","unstructured":"Luo J et al (2016) Association between serum potassium and outcomes in patients with reduced kidney function. Clin J Am Soc Nephrol 11(1):90\u2013100","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"25_CR36","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/eurjhf\/hft134","volume":"15","author":"AP Maggioni","year":"2013","unstructured":"Maggioni AP et al (2013) Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 15(10):1173\u20131184","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"25_CR37","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","volume":"14","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14(8):803\u2013869","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"25_CR38","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ et al (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371(11):993\u20131004","journal-title":"N Engl J Med"},{"key":"25_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13012-014-0169-x","volume":"9","author":"JW Mold","year":"2014","unstructured":"Mold JW et al (2014) Leveraging practice-based research networks to accelerate implementation and diffusion of chronic kidney disease guidelines in primary care practices: a prospective cohort study. Implement Sci 9:169","journal-title":"Implement Sci"},{"key":"25_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2147\/IJNRD.S13871","volume":"3","author":"M Nepal","year":"2010","unstructured":"Nepal M et al (2010) Hypernatremia in a patient treated with sodium polystyrene sulfonate. Int J Nephrol Renovasc Dis 3:141\u2013143","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"23","key":"25_CR41","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","volume":"100","author":"M Packer","year":"1999","unstructured":"Packer M et al (1999) Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation 100(23):2312\u20132318","journal-title":"Circulation"},{"issue":"1","key":"25_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40256-015-0130-7","volume":"16","author":"DK Packham","year":"2016","unstructured":"Packham DK, Kosiborod M (2016) Potential new agents for the management of hyperkalemia. Am J Cardiovasc Drugs. 16(1):19\u201331","journal-title":"Am J Cardiovasc Drugs."},{"issue":"3","key":"25_CR44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1056\/NEJMoa1411487","volume":"372","author":"DK Packham","year":"2015","unstructured":"Packham DK et al (2015) Sodium zirconium cyclosilicate in hyperkalemia. N Engl J Med 372(3):222\u2013231","journal-title":"N Engl J Med"},{"issue":"16","key":"25_CR75","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1056\/NEJMra020676","volume":"347","author":"BF Palmer","year":"2002","unstructured":"Palmer BF (2002) Renal dysfunction complicating the treatment of hypertension. N Engl J Med 347(16):1256\u20131261","journal-title":"N Engl J Med"},{"issue":"6","key":"25_CR45","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMra035279","volume":"351","author":"BF Palmer","year":"2004","unstructured":"Palmer BF (2004) Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med 351(6):585\u2013592","journal-title":"N Engl J Med"},{"issue":"1","key":"25_CR46","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0006-3495(96)79575-9","volume":"70","author":"S Paula","year":"1996","unstructured":"Paula S et al (1996) Permeation of protons, potassium ions, and small polar molecules through phospholipid bilayers as a function of membrane thickness. Biophys J 70(1):339\u2013348","journal-title":"Biophys J"},{"issue":"7","key":"25_CR47","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/eurheartj\/ehq502","volume":"32","author":"B Pitt","year":"2011","unstructured":"Pitt B et al (2011) Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur Heart J 32(7):820\u2013828","journal-title":"Eur Heart J"},{"issue":"10","key":"25_CR48","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/ejhf.402","volume":"17","author":"B Pitt","year":"2015","unstructured":"Pitt B et al (2015) Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors. Eur J Heart Fail 17(10):1057\u20131065","journal-title":"Eur J Heart Fail"},{"key":"25_CR49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ehf2.12005","volume":"1","author":"P Ponikowski","year":"2014","unstructured":"Ponikowski P, Anker SD, AlHabib KF et al (2014) Heart failure: preventing disease and death worldwide. ESC Heart Failure 1:4\u201325","journal-title":"ESC Heart Failure"},{"issue":"5","key":"25_CR50","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1210\/endo-125-5-2463","volume":"125","author":"JH Pratt","year":"1989","unstructured":"Pratt JH et al (1989) Evidence that angiotensin-II and potassium collaborate to increase cytosolic calcium and stimulate the secretion of aldosterone. Endocrinology 125(5):2463\u20132469","journal-title":"Endocrinology"},{"issue":"5","key":"25_CR51","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ki.1990.295","volume":"38","author":"TJ Rabelink","year":"1990","unstructured":"Rabelink TJ et al (1990) Early and late adjustment to potassium loading in humans. Kidney Int 38(5):942\u2013947","journal-title":"Kidney Int"},{"issue":"1","key":"25_CR52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/archinte.158.1.26","volume":"158","author":"LC Reardon","year":"1998","unstructured":"Reardon LC, Macpherson DS (1998) Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry? Arch Intern Med 158(1):26\u201332","journal-title":"Arch Intern Med"},{"issue":"14","key":"25_CR53","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.jacc.2016.06.060","volume":"68","author":"CM Sarwar","year":"2016","unstructured":"Sarwar CM et al (2016) Hyperkalemia in heart failure. J Am Coll Cardiol 68(14):1575\u20131589","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"25_CR54","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1210\/endo-125-1-486","volume":"125","author":"DN Shier","year":"1989","unstructured":"Shier DN et al (1989) Production of renin, angiotensin II, and aldosterone by adrenal explant cultures: response to potassium and converting enzyme inhibition. Endocrinology 125(1):486\u2013491","journal-title":"Endocrinology"},{"issue":"3","key":"25_CR55","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11886-012-0258-x","volume":"14","author":"PA Sobotka","year":"2012","unstructured":"Sobotka PA et al (2012) The role of renal denervation in the treatment of heart failure. Curr Cardiol Rep 14(3):285\u2013292","journal-title":"Curr Cardiol Rep"},{"issue":"5","key":"25_CR56","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00424-009-0781-9","volume":"459","author":"MV Sorensen","year":"2010","unstructured":"Sorensen MV et al (2010) Colonic potassium handling. Pflugers Arch 459(5):645\u2013656","journal-title":"Pflugers Arch"},{"issue":"12","key":"25_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114686","volume":"9","author":"F Stavros","year":"2014","unstructured":"Stavros F et al (2014) Characterization of structure and function of ZS-9, a K+ selective ion trap. PLoS One 9(12):e114686","journal-title":"PLoS One"},{"issue":"5","key":"25_CR58","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1681\/ASN.2010010079","volume":"21","author":"RH Sterns","year":"2010","unstructured":"Sterns RH et al (2010) Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? J Am Soc Nephrol 21(5):733\u2013735","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"25_CR59","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2169\/internalmedicine.46.6415","volume":"46","author":"K Takaichi","year":"2007","unstructured":"Takaichi K et al (2007) Analysis of factors causing hyperkalemia. Intern Med 46(12):823\u2013829","journal-title":"Intern Med"},{"issue":"8","key":"25_CR60","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00392-014-0678-2","volume":"103","author":"U Tebbe","year":"2014","unstructured":"Tebbe U et al (2014) Registry in Germany focusing on level-specific and evidence-based decision finding in the treatment of heart failure: REFLECT-HF. Clin Res Cardiol 103(8):665\u2013673","journal-title":"Clin Res Cardiol"},{"key":"25_CR61","unstructured":"Tumlin JA (2015) Long-term (52-week) efficacy and safety of ZS-9 in the treatment of hyperkalemia: interim results from a phase 3 open-label, multi-center, multi-dose maintenance study. Kidney Week, Nov 2015"},{"issue":"4","key":"25_CR62","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10741-015-9482-y","volume":"20","author":"C Urso","year":"2015","unstructured":"Urso C et al (2015) Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications. Heart Fail Rev 20(4):493\u2013503","journal-title":"Heart Fail Rev"},{"issue":"20","key":"25_CR63","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.jacc.2012.07.048","volume":"60","author":"O Vardeny","year":"2012","unstructured":"Vardeny O et al (2012) Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (randomized Aldactone evaluation study). J Am Coll Cardiol 60(20):2082\u20132089","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"25_CR64","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1161\/CIRCHEARTFAILURE.114.001104","volume":"7","author":"O Vardeny","year":"2014","unstructured":"Vardeny O et al (2014) Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist. Circ Heart Fail 7(4):573\u2013579","journal-title":"Circ Heart Fail"},{"issue":"10","key":"25_CR65","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.2215\/CJN.03700410","volume":"5","author":"M Watson","year":"2010","unstructured":"Watson M et al (2010) Damned if you do, damned if you don\u2019t: potassium binding resins in hyperkalemia. Clin J Am Soc Nephrol 5(10):1723\u20131726","journal-title":"Clin J Am Soc Nephrol"},{"key":"25_CR67","doi-asserted-by":"crossref","unstructured":"Weir M, Bakris G, Gross C, Mayo M, Garza D, Stasiv Y, Yuan J, Berman L, Williams G (2015a) Abstract P602: Patiromer decreased aldosterone, urine albumin\/creatinine ratio, and blood pressure in patients with chronic kidney disease and hyperkalemia on RAAS Inhibitors: results from OPAL-HK. Hypertension 66:AP602. Originally published November 3, 2015. http:\/\/hyper.ahajournals.org\/content\/66\/Suppl_1\/AP602?related-urls=yes&legid=hypertensionaha%3B66%2FSuppl_1%2FAP602","DOI":"10.1161\/hyp.66.suppl_1.p602"},{"issue":"3","key":"25_CR68","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1410853","volume":"372","author":"MR Weir","year":"2015","unstructured":"Weir MR et al (2015b) Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med 372(3):211\u2013221","journal-title":"N Engl J Med"},{"key":"25_CR76","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001278","author":"MR Weir","year":"2017","unstructured":"Weir MR, Mayo MR, Garza D, Arthur SA, Berman L, Bushinsky D, Wilson DJ, Epstein M (2017) Effectiveness of atiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics. J Hypertens. doi: 10.1097\/HJH.0000000000001278","journal-title":"J Hypertens"},{"issue":"12","key":"25_CR69","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1097\/CCM.0b013e31818f222b","volume":"36","author":"LS Weisberg","year":"2008","unstructured":"Weisberg LS (2008) Management of severe hyperkalemia. Crit Care Med 36(12):3246\u20133251","journal-title":"Crit Care Med"},{"issue":"12","key":"25_CR70","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1097\/01.ASN.0000100145.27188.33","volume":"14","author":"WA Wilmer","year":"2003","unstructured":"Wilmer WA et al (2003) Management of glomerular proteinuria: a commentary. J Am Soc Nephrol 14(12):3217\u20133232","journal-title":"J Am Soc Nephrol"},{"issue":"16","key":"25_CR71","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW et al (2013a) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines. J Am Coll Cardiol 62(16):e147\u2013e239","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"25_CR72","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW et al (2013b) 2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines. Circulation 128(16):1810\u20131852","journal-title":"Circulation"},{"issue":"3 Pt 1","key":"25_CR73","first-page":"E328","volume":"247","author":"DB Young","year":"1984","unstructured":"Young DB et al (1984) Multiplicative interaction between angiotensin II and K concentration in stimulation of aldosterone. Am J Phys 247(3 Pt 1):E328\u2013E335","journal-title":"Am J Phys"},{"issue":"9","key":"25_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.02.034","volume":"126","author":"CM Yuan","year":"2013","unstructured":"Yuan CM et al (2013) Incidence of sodium polystyrene sulfonate-associated colonic necrosis. Am J Med 126(9):e13","journal-title":"Am J Med"}],"container-title":["Handbook of Experimental Pharmacology","Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2017_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:50:43Z","timestamp":1692751843000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2017_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319596587","9783319596594"],"references-count":72,"URL":"https:\/\/doi.org\/10.1007\/164_2017_25","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"6 April 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}